The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells

• Published in: Scientific reports 2017-12, Vol.7 (1), p.17062-11, Article 17062
• Main Authors: Akbarzadeh, Maryam, Movassaghpour, Ali Akbar, Ghanbari, Hossein, Kheirandish, Maryam, Fathi Maroufi, Nazila, Rahbarghazi, Reza, Nouri, Mohammad, Samadi, Nasser
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; 13/31; 631/67/1059; 631/67/71; Cadherins - metabolism; CD44 antigen; Cell Line, Tumor; Cell migration; Cell Movement - drug effects; Cell proliferation; Cell Proliferation - drug effects; Cell self-renewal; Down-Regulation - drug effects; E-cadherin; Epithelial-Mesenchymal Transition - drug effects; Female; Gelatinase B; Humanities and Social Sciences; Humans; Invasiveness; Ki-67 Antigen - metabolism; MAP kinase; Matrix metalloproteinase; Matrix Metalloproteinase 2 - genetics; Matrix Metalloproteinase 2 - metabolism; Matrix Metalloproteinase 9 - metabolism; Melatonin; Melatonin - pharmacology; Mesenchyme; Metalloproteinase; Metastases; Metastasis; multidisciplinary; Neoplastic Stem Cells - cytology; Neoplastic Stem Cells - drug effects; Neoplastic Stem Cells - metabolism; Ovarian cancer; Ovarian Neoplasms - metabolism; Ovarian Neoplasms - pathology; Science; Science (multidisciplinary); Stem cells; Vimentin; Vimentin - metabolism
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-017-16940-y

There is an urgent need to identify targeting molecules to control invasion and metastasis in cancer patients. We first isolated cancer stem cells (CSCs) from SKOV3 ovarian cancer cells and then investigated the role of melatonin in invasiveness and migration of CSCs compared to SKOV3 cells. The proportion of CSCs in SKOV3 cells was as low as 1.28% with overexpression of both CD133 and CD44. The ability of spheroid formation along with SOX2 overexpression revealed a high self-renewal potential in isolated cells. Melatonin (3.4 mM) inhibited proliferation of CSCs by 23% which was confirmed by a marked decrease in protein expression of Ki67, as a proliferation marker. Applying luzindole, a melatonin receptor 1, 2 inhibitor, partially abolished anti-proliferative effect of melatonin. Melatonin also decreased Epithelial mesenchymal transition (EMT) related gene expressions including ZEB1, ZEB2, snail and vimentin with increase in E-cadherin as a negative EMT regulator. Incubation of CSCs with melatonin showed a marked decrease in matrix metalloproteinase 9 (MMP9) expression and activity. Melatonin also inhibited CSCs migration in a partially receptor dependent and PI3k and MAPK independent manner. Melatonin can be considered as an important adjuvant to control invasion and metastasis especially in patients with high melatonin receptor expression.